Nearly 100 million people worldwide, including 4 million Americans, are believed to be have hepatitis C.
Typically, only 15 percent to 20 percent of patients who get interferon are rid of all signs of the virus.
The Food and Drug Administration approved a powerful combination of two antiviral drugs to treat chronic hepatitis C, a liver infection that can lead to cirrhosis, liver cancer and liver failure.
, found that six months after treatment, a combination of interferon and a drug called ribavirin was 31 to 38 percent effective among patients being treated for the first time.
1 reason for
